• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

"Pilot pragmatic clinical trial of iron therapy in children with anemia of chronic kidney disease (FeTCh-CKD)" - authors' reply.

作者信息

Baqai Kanza, Furth Susan, Kogon Amy, Akchurin Oleh

机构信息

Division of Pediatric Nephrology, Department of Pediatrics, Weill Cornell Medical College, LC617, 1300 York Ave, New York, NY, 10065, USA.

Perelman School of Medicine, Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Pediatr Nephrol. 2025 Sep 8. doi: 10.1007/s00467-025-06947-3.

DOI:10.1007/s00467-025-06947-3
PMID:40915991
Abstract
摘要

相似文献

1
"Pilot pragmatic clinical trial of iron therapy in children with anemia of chronic kidney disease (FeTCh-CKD)" - authors' reply.“慢性肾脏病贫血患儿铁剂治疗的实用性临床试验（FeTCh-CKD）”——作者回复
Pediatr Nephrol. 2025 Sep 8. doi: 10.1007/s00467-025-06947-3.
2
Pilot pragmatic clinical trial of iron therapy in children with anemia of chronic kidney disease (FeTCh-CKD).慢性肾脏病贫血患儿铁剂治疗的实用性试点临床试验（FeTCh-CKD）
Pediatr Nephrol. 2025 Jul 30. doi: 10.1007/s00467-025-06903-1.
3
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE).Ziltivekimab 对 CKD 3-5 期患者血红蛋白相关因素的影响：一项随机试验（RESCUE）分析。
J Am Soc Nephrol. 2024 Jan 1;35(1):74-84. doi: 10.1681/ASN.0000000000000245. Epub 2023 Dec 13.
4
Darbepoetin for the anaemia of chronic kidney disease.达贝泊汀用于治疗慢性肾脏病贫血
Cochrane Database Syst Rev. 2014 Mar 31;2014(3):CD009297. doi: 10.1002/14651858.CD009297.pub2.
5
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).用于预防和治疗慢性肾脏病-矿物质和骨异常（CKD-MBD）的磷结合剂。
Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3.
6
Dietary interventions for adults with chronic kidney disease.针对成年慢性肾病患者的饮食干预措施。
Cochrane Database Syst Rev. 2017 Apr 23;4(4):CD011998. doi: 10.1002/14651858.CD011998.pub2.
7
Parenteral versus oral iron therapy for adults and children with chronic kidney disease.成人及儿童慢性肾脏病患者的肠外与口服铁剂治疗
Cochrane Database Syst Rev. 2012 Jan 18;1:CD007857. doi: 10.1002/14651858.CD007857.pub2.
8
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.用于治疗慢性肾脏病贫血的持续促红细胞生成素受体激活剂（CERA）
Cochrane Database Syst Rev. 2017 Aug 7;8(8):CD009904. doi: 10.1002/14651858.CD009904.pub2.
9
Efficacy of Roxadustat in Anemia with Chronic Kidney Disease.罗沙司他治疗慢性肾脏病贫血的疗效
Curr Pharm Des. 2025;31(22):1816-1822. doi: 10.2174/0113816128354065250114154721.
10
Oral lactoferrin as a treatment of pediatrics' anemia resulted from chronic kidney diseases: a randomized controlled trial.口服乳铁蛋白治疗儿童慢性肾脏病所致贫血：一项随机对照试验。
Sci Rep. 2025 Feb 5;15(1):4380. doi: 10.1038/s41598-025-88506-2.

引用本文的文献

1
Regarding "Pilot pragmatic clinical trial of iron therapy in children with anemia of chronic kidney disease (FeTCh-CKD)".关于“慢性肾脏病贫血患儿铁剂治疗的实用性临床试验（FeTCh-CKD）”
Pediatr Nephrol. 2025 Sep 10. doi: 10.1007/s00467-025-06950-8.

本文引用的文献

1
Pilot pragmatic clinical trial of iron therapy in children with anemia of chronic kidney disease (FeTCh-CKD).慢性肾脏病贫血患儿铁剂治疗的实用性试点临床试验（FeTCh-CKD）
Pediatr Nephrol. 2025 Jul 30. doi: 10.1007/s00467-025-06903-1.
2
Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages.铁剂治疗通过调节肾巨噬细胞的细胞内铁状态来减轻慢性肾脏病的进展。
JCI Insight. 2023 Jan 10;8(1):e159235. doi: 10.1172/jci.insight.159235.
3
Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels.
血清铁、铁结合能力、转铁蛋白饱和度及铁蛋白水平的昼夜变化。
Am J Clin Pathol. 2002 May;117(5):802-8. doi: 10.1309/2YT4-CMP3-KYW7-9RK1.